ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EicOsis Successfully Completes Phase 1a Clinical Trial of EC5026
December 01, 2020EicOsis Human Health announced the successful completion of a Phase 1a single-ascending dose clinical trial of EC5026, their oral drug candidate for the treatment of pain. -
EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain
April 10, 2020EicOsis announced the U.S. Food & Drug Administration (FDA) has granted Fast Track designation to its lead drug candidate, EC5026, for the treatment of neuropathic pain. -
EicOsis Announces First Subject Dosed in Pain Management Trial
December 16, 2019EicOsis announced initiation of dosing for the first human subject in a Phase 1 trial of EC5026, the company's lead product candidate for pain management.
Pharma Sources Insight January 2025
